Document is current
Any future updates will be listed below
-
Authors
Müller-Wirtz, Lukas M.
O’Gara, Brian
Gama de Abreu, Marcelo
Schultz, Marcus J.
Beitler, Jeremy R.
Jerath, Angela
Meiser, Andreas
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (MU4688-1-1)
National Institutes of Health (R01-HL168102)
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 30 July 2024
First Online: 1 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: Lukas M. Müller-Wirtz received travel expenses and honoraria for lectures from Sedana Medical (Danderyd, Sweden). Brian O’Gara received consulting fees from Sedana Medical. Marcelo Gama de Abreu is a co-investigator of a clinical trial of a volatile anesthetic related to this work which is funded by Sedana Medical. Marcus Schultz and Angela Jerath report no conflicts of interest related to the topic. Jeremy R. Beitler reports prior consulting fees from Arrowhead, Biomarck, and Global Blood Therapeutics for work on scientific advisory committees unrelated to this manuscript, funds from Sedana Medical paid to Columbia University for work as principal investigator of a clinical trial of a volatile anesthetic related to this work, prior consulting fees from Sedana Medical for work on a scientific advisory committee planning the aforementioned trial related to this manuscript, and fees from Hamilton Medical and Stimit for trial safety monitoring roles unrelated to this manuscript. Andreas Meiser received consulting fees from Sedana Medical, as well as travel expenses and honoraria for lectures from Sedana Medical and Cytosorbents Europe (Berlin, Germany).
